2016 Midwest Ovarian Cancer Coalition Workshop Highlights Research, Treatment and Advocacy
Over 70 researchers from a dozen universities in the Midwest gathered at Notre Dame for the 3rd Midwest Ovarian Cancer Coalition (MWOCC)* workshop to discuss the latest advances in ovarian cancer research. With a welcome from Mr. Gene Pranzo, Trustee of conference sponsor The Leo and Anne Albert Charitable Trust, attendees were charged to uphold the wishes of the trust and “do good for humanity”. The good works of the attendees were highlighted in a speed poster session with 3-slide teasers designed to highlight posters in the evening session. A Keynote address was given by Dr. Stephen Baylin, Ludwig professor of oncology and medicine, Johns Hopkins University and Sidney Kimmel Comprehensive Cancer Center. Baylin’s presentation summarized the elegant research from his laboratory and the Van Andel Research Institute – Stand Up to Cancer Epigenetics Dream Team in the area of epigenetic therapy. New advances suggest the ability to more precisely fine-tune combinations of epigenetic therapy with immunotherapy to provide better outcomes for women with advanced ovarian cancer.